Argenx
ARGX
$607.46
Share price
4.57%
Change (1 day)
61.45%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Earnings for Argenx (ARGX)
Earnings in 2024 (TTM): $85.18 Million USD
According to Argenx 's latest financial reports the company's current earnings are $2.19 Billion USD. , an increase over its 2023 earnings that were of -$0.31 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Argenx from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | $85.18 M | -127.97% |
| 2023 | -$0.31 Billion | -58.25% |
| 2022 | -$0.73 Billion | |
| 2019 | -$0.2 Billion | 124.95% |
| 2018 | -$88.5 Million | 132.04% |
| 2017 | -$38.14 Million | 54.86% |
| 2016 | -$24.63 Million | 33% |
| 2015 | -$18.52 Million | 13.63% |
| 2014 | -$16.3 Million | 46.25% |
| 2013 | -$11.15 Million |